Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.

Sunkyu Kim,Ralph Tiedt,Alice Loo,Thomas Horn,Scott Delach,Steven Kovats,Kristy Haas,Barbara Schacher Engstler,Alexander Cao,Maria Pinzon-Ortiz,Iain Mulford,Michael G Acker,Rajiv Chopra,Christopher Brain,Emmanuelle di Tomaso,William R Sellers,Giordano Caponigro

Oncotarget（2020）

Cited 50|Views80

Key words

CDK4/6 inhibitor,LEE011,preclinical,ribociclib,selectivity

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined